EX-10.1



 Exhibit 10.1 

Tenet Healthcare Corporation 

1445 Ross Avenue, Suite 1400 

Dallas, TX 75202 
 November 2, 2016 

Glenview Capital Management, LLC 
 767 Fifth Avenue, 44th Floor

 New York, NY 10153 
 Attention: Mark Horowitz 

Mr. Horowitz, 
 Reference is made to that certain Support
Agreement (the “Support Agreement”), dated January 18, 2016, between Glenview Capital Management, LLC and the entities listed on Schedule A thereto (collectively, “Glenview”) and Tenet Healthcare Corporation
(the “Company”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Support Agreement. 

On or around the date hereof, the Board of Directors of the Company (the “Board”) shall expand the size of the Board by two directors to 14
directors, appoint Peter M. Wilver and John P. Byrnes as directors of the Company and publicly announce such appointment (the later of the effective date of such appointment and such announcement, the “Appointment Date”).

Effective as of the Appointment Date, the Company and Glenview hereby agree that (a) Peter M. Wilver and John P. Byrnes shall be deemed the “Independent
Nominees” pursuant to Section 1(j) of the Support Agreement, (b) the Company shall be deemed to have satisfied its obligation pursuant to Section 1(j) of the Support Agreement and (c) Glenview shall no longer have any rights to propose
individuals for nomination to the Board pursuant to Section 1(j) of the Support Agreement and (d) in accordance with Section 1(k) of the Support Agreement, subject to Glenview’s compliance with Section 2 of the Support Agreement, the Company
agrees to (i) include Peter M. Wilver and John P. Byrnes in its slate of nominees for election as directors of the Company at the 2017 Annual Meeting and (ii) use reasonable best efforts to cause the election of Peter M. Wilver and John P.
Byrnes to the Board at the 2017 Annual Meeting (including recommending that the Company’s shareholders vote in favor of the election of the Independent Nominees (along with all the Company’s nominees) and otherwise supporting Peter M.
Wilver and John P. Byrnes for election in a manner no less rigorous and favorable than the manner in which the Company supports its other nominees in the aggregate). 

Except as expressly provided herein, nothing contained in this letter agreement shall be deemed to amend, alter or modify any of the obligations, covenants or
agreements set forth in the Support Agreement. 
 The parties hereby agree that Section 10, 12, 14, 15, 16, 17 and 19 of the Support Agreement shall apply
to this letter agreement mutatis mutandis as if such provisions were set out herein in full and as if each reference therein to “this Agreement” included a reference to this letter agreement. 







 
					
	Sincerely,
	
	TENET HEALTHCARE CORPORATION
		
	By:	 	 /s/ Paul A. Castanon

		 	Name:	 	Paul A. Castanon
		 	Title:	 	Vice President and Deputy General Counsel


 Accepted and agreed as of the date first written above: 

 

					
	 GLENVIEW CAPITAL MANAGEMENT, LLC,

on behalf of itself and as investment manager to the Glenview Funds

		
	By:	 	 /s/ Mark Horowitz

		 	Name:	 	Mark Horowitz
		 	Title:	 	President


  
 [Signature Page to Letter
Agreement] 








 SCHEDULE A 

Investment Manager 
  

	 	1.	Glenview Capital Management, LLC, a Delaware limited liability company 

 Glenview Funds 

 

	 	1.	Glenview Capital Partners, L.P., a Delaware limited partnership 

  

	 	2.	Glenview Capital Master Fund, Ltd., a Cayman Islands exempted company 

  

	 	3.	Glenview Institutional Partners, L.P., a Delaware limited partnership 

  

	 	4.	Glenview Offshore Opportunity Master Fund, Ltd., a Cayman Islands exempted company 

  

	 	5.	Glenview Capital Opportunity Fund, L.P., a Delaware limited partnership